<bill session="115" type="h" number="5723" updated="2019-04-18T16:23:13Z">
  <state datetime="2018-06-19T16:48:01-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2018-06-19T16:48:01-04:00"/>
  </status>
  <introduced datetime="2018-05-09"/>
  <titles>
    <title type="official" as="introduced">To require the Medicare Payment Advisory Commission to report on opioid payment, adverse incentives, and data under the Medicare program.</title>
    <title type="short" as="passed house">Expanding Oversight of Opioid Prescribing and Payment Act of 2018</title>
    <title type="short" as="passed house">Expanding Oversight of Opioid Prescribing and Payment Act of 2018</title>
    <title type="short" as="reported to house">Expanding Oversight of Opioid Prescribing and Payment Act of 2018</title>
    <title type="short" as="reported to house">Expanding Oversight of Opioid Prescribing and Payment Act of 2018</title>
    <title type="short" as="introduced">Expanding Oversight of Opioid Prescribing and Payment Act of 2018</title>
    <title type="short" as="introduced">Expanding Oversight of Opioid Prescribing and Payment Act of 2018</title>
    <title type="display">Expanding Oversight of Opioid Prescribing and Payment Act of 2018</title>
  </titles>
  <sponsor bioguide_id="T000478"/>
  <cosponsors>
    <cosponsor bioguide_id="D000617" joined="2018-05-09"/>
    <cosponsor bioguide_id="M001180" joined="2018-05-09"/>
    <cosponsor bioguide_id="R000586" joined="2018-05-15"/>
    <cosponsor bioguide_id="S000051" joined="2018-06-05"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-05-09" state="REFERRED">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-09">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-16">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-16" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </calendar>
    <action datetime="2018-05-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-06-19">
      <text>Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.</text>
    </action>
    <action datetime="2018-06-19">
      <text>Committee on Energy and Commerce discharged.</text>
    </action>
    <calendar datetime="2018-06-19" calendar="Union" number="592">
      <text>Placed on the Union Calendar, Calendar No. 592.</text>
    </calendar>
    <action datetime="2018-06-19T16:37:02-04:00">
      <text>Mr. Roskam moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2018-06-19T16:37:14-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5264-5265" label="consideration"/>
    </action>
    <action datetime="2018-06-19T16:37:16-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2018-06-19T16:48:01-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5264" label="text"/>
    </vote>
    <action datetime="2018-06-19T16:48:29-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2018-06-20">
      <text>Received in the Senate and Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Discharged, Referral"/>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="6"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health information and medical records"/>
    <term name="Home and outpatient care"/>
    <term name="Hospital care"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-19T09:09:29Z" status="Passed House amended">Expanding Oversight of Opioid Prescribing and Payment Act of 2018

(Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on:&#160;(1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.</summary>
  <committee-reports>
    <report>H. Rept. 115-760</report>
  </committee-reports>
</bill>
